171 related articles for article (PubMed ID: 7714743)
1. Absorption of transdermally delivered ketorolac acid in humans.
Roy SD; Manoukian E; Combs D
J Pharm Sci; 1995 Jan; 84(1):49-52. PubMed ID: 7714743
[TBL] [Abstract][Full Text] [Related]
2. Transdermal delivery of ketorolac tromethamine: permeation enhancement, device design, and pharmacokinetics in healthy humans.
Roy SD; Manoukian E
J Pharm Sci; 1995 Oct; 84(10):1190-6. PubMed ID: 8801333
[TBL] [Abstract][Full Text] [Related]
3. Permeability of pure enantiomers of ketorolac through human cadaver skin.
Roy SD; Chatterjee DJ; Manoukian E; Divor A
J Pharm Sci; 1995 Aug; 84(8):987-90. PubMed ID: 7500285
[TBL] [Abstract][Full Text] [Related]
4. Permeability of ketorolac acid and its ester analogs (prodrug) through human cadaver skin.
Roy SD; Manoukian E
J Pharm Sci; 1994 Nov; 83(11):1548-53. PubMed ID: 7891272
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous absorption of nicardipine and ketorolac in rhesus monkeys.
Yu D; Sanders LM; Davidson GW; Marvin MJ; Ling T
Pharm Res; 1988 Jul; 5(7):457-62. PubMed ID: 3266795
[TBL] [Abstract][Full Text] [Related]
6. In vivo/in vitro correlations for four differently dissolving ketorolac tablets.
Gordon MS; Chowhan Z
Biopharm Drug Dispos; 1996 Aug; 17(6):481-92. PubMed ID: 8866039
[TBL] [Abstract][Full Text] [Related]
7. Effect of benzalkonium chloride/EDTA on the ocular bioavailability of ketorolac tromethamine following ocular instillation to normal and de-epithelialized corneas of rabbits.
Madhu C; Rix PJ; Shackleton MJ; Nguyen TG; Tang-Liu DD
J Pharm Sci; 1996 Apr; 85(4):415-8. PubMed ID: 8901080
[TBL] [Abstract][Full Text] [Related]
8. Passive versus electrotransport-facilitated transdermal absorption of ketorolac.
Park K; Verotta D; Gupta SK; Sheiner LB
Clin Pharmacol Ther; 1998 Mar; 63(3):303-15. PubMed ID: 9542474
[TBL] [Abstract][Full Text] [Related]
9. Transdermal delivery of ketorolac tromethamine: effects of vehicles and penetration enhancers.
Cho YA; Gwak HS
Drug Dev Ind Pharm; 2004 Jul; 30(6):557-64. PubMed ID: 15285328
[TBL] [Abstract][Full Text] [Related]
10. Nasal formulations of ketorolac tromethamine: technological evaluation--bioavailability and tolerability in rabbits.
Santus G; Rivolta R; Bottoni G; Testa B; Canali S; Peano S
Farmaco; 1993 Dec; 48(12):1709-23. PubMed ID: 8135994
[TBL] [Abstract][Full Text] [Related]
11. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
Aboofazeli R; Zia H; Needham TE
Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
[TBL] [Abstract][Full Text] [Related]
12. Formulation and in vitro/in vivo evaluation of levodopa transdermal delivery systems.
Lee KE; Choi YJ; Oh BR; Chun IK; Gwak HS
Int J Pharm; 2013 Nov; 456(2):432-6. PubMed ID: 24008082
[TBL] [Abstract][Full Text] [Related]
13. Formulation and evaluation of ketorolac transdermal systems.
Choi JS; Cho YA; Chun IK; Jung SY; Gwak HS
Drug Deliv; 2007 Feb; 14(2):69-74. PubMed ID: 17364870
[TBL] [Abstract][Full Text] [Related]
14. Impact of ester promoieties on transdermal delivery of ketorolac.
Liu KS; Hsieh PW; Aljuffali IA; Lin YK; Chang SH; Wang JJ; Fang JY
J Pharm Sci; 2014 Mar; 103(3):974-86. PubMed ID: 24481782
[TBL] [Abstract][Full Text] [Related]
15. Ketorolac tromethamine transdermal gel: development, in vitro and in vivo evaluation.
Dubey R; Bommagani M; Venkateswarlu V; Mullangi R; Karnati HR; Thammera RK; Menon VC
J Pain Palliat Care Pharmacother; 2009; 23(1):26-34. PubMed ID: 19296352
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of two sublingual formulations of ketorolac tromethamine 30 mg: a randomized, open-label, single-dose, two-period crossover comparison in healthy Mexican adult volunteers.
Galán-Herrera JF; Poo JL; Maya-Barrios JA; de Lago A; Oliva I; González-de la Parra M; Jiménez P; López-Bojórquez E; Burke-Fraga V; Namur S
Clin Ther; 2008 Sep; 30(9):1667-74. PubMed ID: 18840372
[TBL] [Abstract][Full Text] [Related]
17. Transdermal delivery of buprenorphine through cadaver skin.
Roy SD; Roos E; Sharma K
J Pharm Sci; 1994 Feb; 83(2):126-30. PubMed ID: 8169777
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of the transdermal penetration of a series of nonsteroidal antiinflammatory drugs.
Cordero JA; Alarcon L; Escribano E; Obach R; Domenech J
J Pharm Sci; 1997 Apr; 86(4):503-8. PubMed ID: 9109056
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of nasal formulations of ketorolac.
Quadir M; Zia H; Needham TE
Drug Deliv; 2000; 7(4):223-9. PubMed ID: 11195429
[TBL] [Abstract][Full Text] [Related]
20. Rapid pain relief using transdermal film forming polymeric solution of ketorolac.
Ammar HO; Ghorab M; Mahmoud AA; Makram TS; Ghoneim AM
Pharm Dev Technol; 2013; 18(5):1005-16. PubMed ID: 22191998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
